🇺🇸 FDA
Pipeline program

Anti-infective therapy

20230901

Unknown small_molecule active

Quick answer

Anti-infective therapy for Bronchiectasis Adult is a Unknown program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Bronchiectasis Adult
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials